依視路®星趣控®2.0鏡片

依視路®星趣控®2.0鏡片的優點

雙倍減速盾 : 近視管理成效更高

矯正近視 : 根據孩子的度數提供清晰視力

無需妥協 : 美觀、簡約又安全

第一代依視路®星趣控®鏡片在2020年上市，緩減近視加深平均達67%，已幫助全球幾百萬兒童延緩近視進展。

 建基於第一代的成功，依視路®星趣控®2.0鏡片配備雙倍減速盾，相比第一代依視路®星趣控®鏡片，近視管理成效更高。

延緩近視加深

依視路®星趣控®2.0鏡片配備雙倍近視減速信號區，相比第一代依視路®星趣控®鏡片，近視管理成效顯著。更高管理成效受臨床測試結果支持。 

  • 矯正近視
    根據孩子的度數提供清晰視力
  • 近視管理
    H.A.L.T. MAX技術，延緩眼軸增長

Reference:

  • Twice the power refers to two (or more) times the depth of volume of non-focused light (by design) compared to that of Essilor® Stellest® lenses—and is not associated with a doubling of lens power, lenslet power, or efficacy.
  • Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children.
  • Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.
  • No significant difference in distance BCVA between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses when looking through the central zone of the lens (Drobe B, et al. Effect of increased power and asphericity of lenslets in myopia control spectacle lenses on short-term visual performance. Invest Ophthalmol Vis Sci. 2025;66:2144)
  • When looking through the peripheral aspherical lenslet portion of the lens, there was no significant difference between Essilor® Stellest® and Essilor® Stellest® 2.0 lenses in high contrast distance visual acuity (VA), low contrast distance VA and low contrast near VA (EssilorLuxottica. Data on File. 2025 Effect of increased power and asphericity of lenslets in myopia control spectacle lenses on short-term visual performance.)
  • Essilor® Stellest® 2.0 lenses are made from AIRWEAR® polycarbonate which provides impact-resistance and blocks 100% transmission of UV.
  • Compared to single vision lenses, when worn 12 hours per day every day for two consecutive years.
  • Bao J, et al. Spectacle lenses with aspherical lenslets for myopia control vs single-vision spectacle lenses: a randomized clinical trial. JAMA ophthalmology. 2022;140(5):472-8;
  • H.A.L.T. is an acronym for Highly Aspherical Lenslet Target and does not imply a “halt” or “stop” of myopia progression.
  • Twice the signal refers to two (or more) times the depth of volume of non-focused light (by design) compared to that of Essilor® Stellest® lenses and is not associated with a doubling of lens power, lenslet power, or efficacy.
  • Based on 12-month results from a prospective, randomized, double-masked contralateral crossover clinical trial conducted in Singapore on 50 children.
  • Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.
  • Raveendran RN, et al. Effect of increased power and asphericity of highly aspherical lenslets on myopia control efficacy: a contralateral crossover study. Transl Vis Sci Technol. 2025;14(11):9.